Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976 Nov;295(2):177-81.
doi: 10.1007/BF00499452.

Contribution of vasopressor and plasma kininogen changes towards acute adrenaline pulmonary edema in the rat

Contribution of vasopressor and plasma kininogen changes towards acute adrenaline pulmonary edema in the rat

A M Rothschild et al. Naunyn Schmiedebergs Arch Pharmacol. 1976 Nov.

Abstract

Acute pulmonary edema, evidenced by increased lung/body weight ratios, was evoked in rats within 5 min following the intravenous injection of 16-40 mug/kg of adrenaline. This change was accompanied by a decrease of 40% of circulatory kininogen not due to generalized plasma protein loss. Rats treated 10-20 min prior to adrenaline with 10 mg/kg of acetylsalicylate (Aspirin), 1000 KIU/kg of Kunitz anti-protease (Trasylol), or 10 mg/kg of soybean trysin inhibitor (SBTI), failed to exhibit pulmonary edema or decreased plasma kininogen levels, but were as sensitive as untreated animals to the arterial hypertensive effect of adrenaline. 4.8 mug/kg of carbamylcholine administered together with 40 mug/kg of adrenaline, prevented pulmonary edema. Carbamylcholine did not reduce plasma kininogen consumption by adrenaline, but effectively decreased the raised systolic arterial blood pressure, the increased systolic-diastolic pressure interval as well as the reflex slowing of the heart presented by adrenaline-treated rats. It seems that in the adrenaline-treated rat, pulmonary edema results from the joined action of vasopressor effects leading to hydrostatically forced outflow of vascular fluid, and of kinin release leading to increased peripheral vascular permeability.

PubMed Disclaimer

References

    1. Br J Anaesth. 1971 Jul;43(7):709-12 - PubMed
    1. Nat New Biol. 1972 May 10;237(71):59-61 - PubMed
    1. Adv Exp Med Biol. 1976;70(00):197-200 - PubMed
    1. J Pathol Bacteriol. 1966 Jul;92(1):151-61 - PubMed
    1. Pharmacol Rev. 1962 Jun;14:251-80 - PubMed

LinkOut - more resources